These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The role of TNF-alpha during Wallerian degeneration. Liefner M, Siebert H, Sachse T, Michel U, Kollias G, Brück W. J Neuroimmunol; 2000 Aug 01; 108(1-2):147-52. PubMed ID: 10900348 [Abstract] [Full Text] [Related]
12. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. Shamash S, Reichert F, Rotshenker S. J Neurosci; 2002 Apr 15; 22(8):3052-60. PubMed ID: 11943808 [Abstract] [Full Text] [Related]
13. Toll-Like Receptor 3 Contributes to Wallerian Degeneration after Peripheral Nerve Injury. Lee H, Baek J, Min H, Cho IH, Yu SW, Lee SJ. Neuroimmunomodulation; 2016 Apr 15; 23(4):209-216. PubMed ID: 27771719 [Abstract] [Full Text] [Related]
14. FGF9 alters the Wallerian degeneration process by inhibiting Schwann cell transformation and accelerating macrophage infiltration. Lv W, Deng B, Duan W, Li Y, Song X, Ji Y, Li Z, Liu Y, Wang X, Li C. Brain Res Bull; 2019 Oct 15; 152():285-296. PubMed ID: 31220553 [Abstract] [Full Text] [Related]
16. Wallerian degeneration in ICAM-1-deficient mice. Vougioukas VI, Roeske S, Michel U, Brück W. Am J Pathol; 1998 Jan 15; 152(1):241-9. PubMed ID: 9422541 [Abstract] [Full Text] [Related]
17. Quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic nerve. Lawson LJ, Frost L, Risbridger J, Fearn S, Perry VH. J Neurocytol; 1994 Dec 15; 23(12):729-44. PubMed ID: 7897440 [Abstract] [Full Text] [Related]